Gregg Katz, a partner in Goodwin’s Technology Companies group, works on a wide variety of public and private securities offerings, mergers and acquisitions and other complex transactions. His practice centers on technology companies, including clients in the software, hardware, biotechnology, pharmaceuticals and other technology-driven industries.

Mr. Katz’ representation of start-up and later-stage companies spans the entire corporate lifecycle, including pre-incorporation planning, venture capital financings, public offerings, SEC reporting and disclosure, mergers and acquisitions, and general corporate representation and counseling.





Mr. Katz’ transactional experience includes representing: 

Public Offerings - Issuer

  • Bluebird bio, a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, in its $116 million initial public offering on NASDAQ and in five follow-on public offerings totaling $1.6 billion  
  • Aquaventure Holdings, a multinational provider of water-as-a-service solutions, in its $135 million initial public offering on NYSE
  • Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in two follow-on public offerings totaling $1.7 billion
  • Eloqua, a provider of on-demand revenue performance management software solutions, in its $106 million initial public offering on NASDAQ
  • Omthera Pharmaceuticals, a pharmaceutical company focused on therapies for abnormalities in blood lipids and the treatment of cardiovascular disease, in its $64 million initial public offering on NASDAQ

Public Offerings - Underwriter

  • Goldman Sachs and Morgan Stanley in the $300 million initial public offering of Blue Apron on NYSE
  • Goldman Sachs, Credit Suisse and Bank of America in the $113 million initial public offering of on NASDAQ
  • Goldman Sachs and Deutsche Bank in the $235 million and $344 million follow-on public offerings of CyberArk Software
  • J.P. Morgan and Deutsche Bank in the $99 million initial public offering of CyberArk Software on NASDAQ 
  • Goldman Sachs and Credit Suisse in the $133 million initial public offering of 2U on NASDAQ and in two follow-on offerings totaling $343 million
  • Stifel in the $57 million initial public offering of SPS Commerce on NASDAQ and in four follow-on offerings totaling $172 million

Private Financings

  • Toast, a provider of restaurant point-of-sale and management systems, in its Series B and Series C financings
  • Salsify, a product content management platform for distributed commerce, in its Series A, Series B and Series C financings
  • Circle Internet Financial, a digital currency company, in its Series A, Series B, Series C and Series D financings
  • Alnylam Pharmaceuticals, a leading RNAi therapeutics company, in a $700 million equity financing closed in connection with Alnylam’s collaboration with Genzyme
  • Carrick Therapeutics, a European oncology company, in its initial funding round
  • Genomics Medicine Ireland, an Irish genomics research company, in its Series A financing
  • TellusLabs, a satellite imagery and machine learning company, in its seed financing
  • Innophase, an innovative semiconductor company, in its Series B financing
  • Infinio Systems, a leader in storage acceleration for virtualized data centers, in its Series B financing
  • Bedford Funding in its Series C investment in Voalte and Series D investment in MDLIVE

Mergers & Acquisitions

  • Teva Pharmaceutical Industries, a leading global pharmaceutical company, in the sale of its specialty women’s global health business
  • iRobot Corporation, a leading global consumer robot company in its acquisitions of Robopolis SAS and Evolution Robotics and in the sale of its Defense & Security business to Arlington Capital Partners
  • Code42 Software, a leader in cloud-based endpoint data protection and recovery, in the sale of its consumer business to Carbonite
  • Plex Systems, a leader in cloud ERP for manufacturing, in its acquisition of DemandCaster
  • Epidemico, an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health, in its sale to Booz Allen Hamilton
  • bluebird bio in its acquisition of Precision Genome Engineering
  • Eloqua, a leading provider of on-demand revenue performance management software solutions, in its sale to Oracle Corporation
  • Endeca Technologies, a provider of unstructured data management, web commerce and business intelligence solutions, in its sale to Oracle Corporation
  • Attend, an event software company, in its sale to Event Farm
  • WaveMark, a provider of real-time healthcare supply chain solutions, in its sale to Cardinal Health
Professional Activities

Mr. Katz is a member of the Massachusetts and Boston Bar Associations. He also serves on the board of directors of the Hillel Council of New England.


While attending law school, Mr. Katz was the articles editor of the Boston College Law Review, for which he authored "Conflicting Fiduciary Duties Within Collegiate Athletic Conferences: A Prescription for Leniency."

In The News









J.D., 2006
Boston College Law School

(magna cum laude, Order of the Coif)

A.B., 2001
Duke University

(magna cum laude)



Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique